Clik here to view.
ConMed proxy war gets ugly
UPDATED March 4, 2014, with comment from Coppersmith Capital. The proxy war over control of the board at ConMed (NSDQ:CNMD) turned ugly this week after serious allegations surfaced against 1 of the...
View ArticleClik here to view.
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly February 28, 2014 by Brad Perriello The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical...
View ArticleClik here to view.
ConMed delays annual meeting amid proxy war
ConMed (NSDQ:CNMD) said last week that it’s delaying its annual shareholders meeting amid a 3-way proxy war that turned nasty last month. Utica, N.Y.-based ConMed acknowledged March 14 a slate of...
View ArticleClik here to view.
K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories...
Spinal firm K2M aims for $100M IPO March 14, 2014 by Arezu Sarvestani Spinal surgery devices maker K2M Group Holdings hopes to raise as much as $100 million through its impending initial public...
View ArticleClik here to view.
Embattled ConMed surges on reports of potential sale
Surgical devices maker ConMed (NSDQ:CNMD) got a little Wall Street love after news sources reported today that the company may be up for sale. Anonymous sources told the Reuters news service that...
View ArticleClik here to view.
Activist investor battles on over ConMed as shareholders vote approaches
A bitter war for control of ConMed (NSDQ:CNMD) is heating up as the medical device company’s annual meeting looms, with a hedge fund pressing hard to win shareholders’ votes for its board nominees....
View ArticleClik here to view.
Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news...
Will Medtronic follow Walgreen and abandon inversion in Covidien deal? August 15, 2014 by Brad Perriello Medtronic might elect to alter the terms of its $43 billion offer to acquire Covidien over...
View Article